These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11777271)

  • 1. Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides.
    Skacel M; Pettay JD; Tsiftsakis EK; Procop GW; Biscotti CV; Tubbs RR
    Anal Quant Cytol Histol; 2001 Dec; 23(6):381-7. PubMed ID: 11777271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of bladder cancer by multitarget multicolour FISH: comparative analysis on archival cytology and paraffin-embedded tissue.
    Mezzelani A; Dagrada G; Alasio L; Sozzi G; Pilotti S
    Cytopathology; 2002 Oct; 13(5):317-25. PubMed ID: 12421448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes.
    Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K
    Anal Quant Cytol Histol; 1994 Feb; 16(1):1-10. PubMed ID: 8011035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of numerical chromosomal abnormalities by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes on archival cytologic samples.
    Cajulis RS; Frias-Hidvegi D; Yu GH; Eggena S
    Diagn Cytopathol; 1996 Mar; 14(2):178-81. PubMed ID: 8964177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
    Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X
    Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice.
    Laudadio J; Keane TE; Reeves HM; Savage SJ; Hoda RS; Lage JM; Wolff DJ
    BJU Int; 2005 Dec; 96(9):1280-5. PubMed ID: 16287445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
    Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
    Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?
    Bollmann M; Heller H; Bánkfalvi A; Griefingholt H; Bollmann R
    BJU Int; 2005 Jun; 95(9):1219-25. PubMed ID: 15892805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples.
    Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Zilberstien Y; Friberger A; Kidron D; Kaplan E; Lew S; Leibovitch I
    Urology; 2005 Dec; 66(6):1354-9. PubMed ID: 16360483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.
    Sarosdy MF; Schellhammer P; Bokinsky G; Kahn P; Chao R; Yore L; Zadra J; Burzon D; Osher G; Bridge JA; Anderson S; Johansson SL; Lieber M; Soloway M; Flom K
    J Urol; 2002 Nov; 168(5):1950-4. PubMed ID: 12394683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder.
    Fritsche HM; Burger M; Dietmaier W; Denzinger S; Bach E; Otto W; Doblinger M; Schwarz S; Buchner H; Hartmann A
    Am J Clin Pathol; 2010 Oct; 134(4):597-603. PubMed ID: 20855641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study.
    Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K; Bacus JW
    Diagn Cytopathol; 1995 Oct; 13(3):214-23; discussion 224. PubMed ID: 8575280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved filter method for urine sediment detection of urothelial carcinoma by fluorescence in situ hybridization.
    Meiers I; Singh H; Hossain D; Lang K; Liu L; Qian J; Verhest AP; Bostwick DG
    Arch Pathol Lab Med; 2007 Oct; 131(10):1574-7. PubMed ID: 17922595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
    Sokolova IA; Halling KC; Jenkins RB; Burkhardt HM; Meyer RG; Seelig SA; King W
    J Mol Diagn; 2000 Aug; 2(3):116-23. PubMed ID: 11229514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine.
    Dalquen P; Kleiber B; Grilli B; Herzog M; Bubendorf L; Oberholzer M
    Cancer; 2002 Dec; 96(6):374-9. PubMed ID: 12478686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
    Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
    Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.